Based on these characterized metabolites in vivo, the NP analysis reveals that the mechanism of SO against TCP is related to the following pathways in cancer: PI3K-Akt, MAPK, JAK-STAT, VEGF, chemokine, actin cytoskeleton, HIF-1, and pluripotency of stem cells. The gene discussed is AKT1; the disease is cancer.